- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01490554
Autologous Fibroblast Grafts in Facial Skin Regeneration
July 23, 2012 updated by: LYDIA MASAKO FERREIRA, Federal University of São Paulo
Effectiveness of Autologous Fibroblast Grafts in the Regeneration of Facial Ectoderm
The purpose of this study is to evaluate the presence of skin changes after grafting of autologous fibroblasts by means of biophysical, histological, immunohistological, gene expression, glycosaminoglycan, and sensitivity analyses.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
- Analytical prospective autocontrolled study
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Women, aged between 50 to 70 years with facial wrinkles (rhytides),
- Fitzpatrick III skin type, and
- Who had reached menopause at least 3 years before entering the study were eligible for participation.
Exclusion Criteria:
- Women with uncontrolled comorbid conditions,
- Smokers,
- Alcohol and corticosteroid users,
- Who had undergone chemical peeling or skin filling in the face or neck at least 12 months prior to the study,
- Who had a keloid scar,
- Who scored below 18 on the Mini-Mental State Examination,
- Who had any psychiatric disorder or those undergoing orthodontic treatment were excluded from the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: autologous fibroblast grafts
|
Autologous cultured fibroblasts will be grafted in facial skin
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Regeneration of facial ectoderm
Time Frame: one year after the grafting of autologous fibroblasts.
|
To evaluate the presence of skin changes after grafting of autologous fibroblasts by means of biophysical, histological, immunohistological, gene expression, glycosaminoglycan, and sensitivity analyses.
|
one year after the grafting of autologous fibroblasts.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Lydia M Ferreira, MD, PhD, Federal University of São Paulo
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2007
Primary Completion (Actual)
March 1, 2011
Study Completion (Anticipated)
December 1, 2012
Study Registration Dates
First Submitted
December 9, 2011
First Submitted That Met QC Criteria
December 12, 2011
First Posted (Estimate)
December 13, 2011
Study Record Updates
Last Update Posted (Estimate)
July 24, 2012
Last Update Submitted That Met QC Criteria
July 23, 2012
Last Verified
July 1, 2012
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- CEP UNIFESP-1787/07
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skin Aging
-
Mert ErsanNot yet recruitingSkin Aging | Skin Quality | Facial Aging
-
Amazentis SAproDERM GmbHCompleted
-
IAS Skin CareCompletedSkin Aging | Transepidermal Water Loss | Skin Hydration | Facial AgingUnited States
-
ChinaNormCompletedMenopause | Skin Aging | Genetic Factors | Reproductive AgingChina
-
AB Biotics, SADr. Goya Análisis, SL.Not yet recruitingSkin | Face Skin Photoaging | Fine Lines | Face Aging/Photo Aging of Moderate Grade | Skin Ageing
-
Hanpoong Nature Pharm Co., Ltd.Completed
-
Mesoestetic Pharma Group S.L.CompletedSkin Aging | Skin WrinklingBulgaria
-
Endymion Medical LtdCompleted
-
Espad PharmedCompletedSkin AgingIran, Islamic Republic of
-
Victoria CollottaActive, not recruiting
Clinical Trials on autologous fibroblasts grafts
-
King's College LondonUniversity College, LondonCompletedRecessive Dystrophic Epidermolysis BullosaUnited Kingdom
-
Johns Hopkins UniversityUnited States Department of Defense; National Institutes of Health (NIH); Maryland...RecruitingAmputation | Skin Wound | Stem CellUnited States
-
Castle Creek Biosciences, LLC.WithdrawnRestrictive Burn Scars of Joint AreaUnited States
-
Castle Creek Biosciences, LLC.CompletedInterdental Papillary InsufficiencyUnited States
-
Castle Creek Biosciences, LLC.CompletedFacial Wrinkles and CreasesUnited States
-
Castle Creek Biosciences, LLC.TerminatedRestrictive Burn ScarsUnited States
-
Johns Hopkins UniversityNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsRecruiting
-
Tego Science, Inc.CompletedTear Trough Eyelid DeformityKorea, Republic of
-
Castle Creek Biosciences, LLC.CompletedAcne Scarring of the FaceUnited States
-
Castle Creek Biosciences, LLC.CompletedBilateral Nasolabial Fold WrinklesUnited States